Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Apatinib
Sponsor: Fudan University
Collaborators: Jiangsu HengRui Medicine Co., Ltd.